• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

斑秃患者与对照组血清白细胞介素10、12、17和35浓度的比较。

Comparison of serum concentrations of interleukins 10, 12, 17 and 35 between patients with alopecia areata and controls.

作者信息

Wojciechowska-Zdrojowy Marta, Jankowska-Konsur Alina, Nowicka-Suszko Danuta, Szepietowski Jacek C, Hryncewicz-Gwóźdź Anita

机构信息

Department of Dermatology, Venereology and Allergology, Wroclaw Medical University, Wroclaw, Poland.

出版信息

Postepy Dermatol Alergol. 2021 Dec;38(6):1052-1057. doi: 10.5114/ada.2021.112278. Epub 2022 Jan 7.

DOI:10.5114/ada.2021.112278
PMID:35126014
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8802955/
Abstract

INTRODUCTION

Alopecia areata (AA) is one of the most common causes of non-scarring hair loss in adults and children with unknown etiopathogenesis, however immunological factors play an important role.

AIM

To evaluate the concentration of interleukin (IL) 10 (IL-10), IL-12, IL-17 and IL-35 in the blood serum of patients with AA.

MATERIAL AND METHODS

AA study group consisted of 118 patients. The control group consisted of 54 healthy individuals. The severity of the disease was assessed by SALT score. In the study group, the percentage of hair loss averaged 49.6% ±36.3%. The concentration of IL-10, IL-12, IL-17 and IL-35 in the serum was assessed by the enzyme-linked immunosorbent assays (ELISA).

RESULTS

In patients with AA, the level of IL-12 and IL-17 was significantly higher than in the control group ( > 0.05). The level of IL-10 in patients was slightly higher, whereas the level of IL-35 was slightly lower, compared to the control group, but those differences were not statistically significant. Furthermore, in patients with more severe disease the IL-12 level was significantly higher as compared to patients with the less severe AA ( < 0.05).

CONCLUSIONS

The etiopathogenesis of AA is complex, however Th1 and Th17 lymphocytes and their increased activity are undoubtedly significant contributors in this process. Disorders of immunological processes in AA require further research in order to understand the underlying pathomechanisms of the disease and to provide potential therapeutic strategies.

摘要

引言

斑秃(AA)是成人和儿童非瘢痕性脱发的最常见原因之一,其发病机制尚不清楚,但免疫因素起着重要作用。

目的

评估斑秃患者血清中白细胞介素(IL)10、IL - 12、IL - 17和IL - 35的浓度。

材料与方法

AA研究组由118例患者组成。对照组由54名健康个体组成。通过SALT评分评估疾病的严重程度。在研究组中,脱发百分比平均为49.6%±36.3%。采用酶联免疫吸附测定(ELISA)法评估血清中IL - 10、IL - 12、IL - 17和IL - 35的浓度。

结果

AA患者中,IL - 12和IL - 17水平显著高于对照组(P>0.05)。与对照组相比,患者的IL - 10水平略高,而IL - 35水平略低,但这些差异无统计学意义。此外,与病情较轻的AA患者相比,病情较重的患者IL - 12水平显著更高(P<0.05)。

结论

AA的发病机制复杂,然而Th1和Th17淋巴细胞及其活性增加无疑是这一过程中的重要因素。AA免疫过程的紊乱需要进一步研究,以了解该疾病的潜在病理机制并提供潜在的治疗策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd33/8802955/2c75105a5cef/PDIA-38-46039-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd33/8802955/9672230eaac8/PDIA-38-46039-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd33/8802955/406415999e8a/PDIA-38-46039-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd33/8802955/2c75105a5cef/PDIA-38-46039-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd33/8802955/9672230eaac8/PDIA-38-46039-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd33/8802955/406415999e8a/PDIA-38-46039-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd33/8802955/2c75105a5cef/PDIA-38-46039-g003.jpg

相似文献

1
Comparison of serum concentrations of interleukins 10, 12, 17 and 35 between patients with alopecia areata and controls.斑秃患者与对照组血清白细胞介素10、12、17和35浓度的比较。
Postepy Dermatol Alergol. 2021 Dec;38(6):1052-1057. doi: 10.5114/ada.2021.112278. Epub 2022 Jan 7.
2
Evaluation of the level of serum Interleukins (IL-2, IL-4, IL-15 andIL-17) and its relationship with disease severity in patients with alopecia areata.评价斑秃患者血清白细胞介素(IL-2、IL-4、IL-15 和 IL-17)水平及其与疾病严重程度的关系。
An Bras Dermatol. 2021 Sep-Oct;96(5):551-557. doi: 10.1016/j.abd.2021.03.006. Epub 2021 Jul 17.
3
SERUM LEVELS OF IL-2 AND IL-17A ARE RELATED TO CLINICAL TYPE AND SEVERITY OF ALOPECIA AREATA.血清白介素-2 和白介素-17A 水平与斑秃临床类型和严重程度相关。
Wiad Lek. 2022;75(1 pt 2):263-267.
4
Serum level of interleukin-15 in active alopecia areata patients and its relation to age, sex, and disease severity.活动期斑秃患者血清白细胞介素-15水平及其与年龄、性别和疾病严重程度的关系。
Postepy Dermatol Alergol. 2020 Dec;37(6):904-908. doi: 10.5114/ada.2020.102103. Epub 2021 Jan 6.
5
The profile of cytokines (IL-2, IFN-γ, IL-4, IL-10, IL-17A, and IL-23) in active alopecia areata.活动期斑秃患者细胞因子(IL-2、IFN-γ、IL-4、IL-10、IL-17A 和 IL-23)谱。
J Cosmet Dermatol. 2020 Jan;19(1):234-240. doi: 10.1111/jocd.12970. Epub 2019 May 14.
6
T-helper 17 cytokines (interleukins 17, 21, 22, and 6, and tumor necrosis factor-α) in patients with alopecia areata: association with clinical type and severity.斑秃患者的辅助性T细胞17细胞因子(白细胞介素17、21、22和6以及肿瘤坏死因子-α):与临床类型和严重程度的关联
Int J Dermatol. 2016 Jun;55(6):666-72. doi: 10.1111/ijd.12808. Epub 2015 Jul 31.
7
Changes and significance of Th1/Th2 and Treg/Th17 cells and their cytokines in patients with alopecia areata.斑秃患者 Th1/Th2、Treg/Th17 细胞及其细胞因子的变化及意义。
Exp Cell Res. 2024 Oct 1;442(2):114259. doi: 10.1016/j.yexcr.2024.114259. Epub 2024 Sep 16.
8
Increased serum interleukin- 17A levels correlate with disease severity and poor prognostic factors in patients with alopecia areata.斑秃患者血清白细胞介素-17A水平升高与疾病严重程度及不良预后因素相关。
Dermatol Reports. 2021 Oct 27;14(2):9398. doi: 10.4081/dr.2021.9398. eCollection 2022 Jun 16.
9
Serum concentrations of selected proinflammatory cytokines in children with alopecia areata.斑秃患儿血清中特定促炎细胞因子的浓度。
Postepy Dermatol Alergol. 2019 Feb;36(1):63-69. doi: 10.5114/ada.2019.82826. Epub 2019 Feb 22.
10
Serum Interleukin-15 is a Marker of Alopecia Areata Severity.血清白细胞介素-15是斑秃严重程度的一个标志物。
Int J Trichology. 2019 Jan-Feb;11(1):26-30. doi: 10.4103/ijt.ijt_80_18.

引用本文的文献

1
Mesenchymal Stem Cell Therapy in Alopecia Areata: Visual and Molecular Evidence from a Mouse Model.间充质干细胞治疗斑秃:来自小鼠模型的视觉和分子证据。
Int J Mol Sci. 2024 Aug 26;25(17):9236. doi: 10.3390/ijms25179236.

本文引用的文献

1
Short-Term Efficacy and Safety of IL-17, IL-12/23, and IL-23 Inhibitors Brodalumab, Secukinumab, Ixekizumab, Ustekinumab, Guselkumab, Tildrakizumab, and Risankizumab for the Treatment of Moderate to Severe Plaque Psoriasis: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials.短期疗效和安全性的白介素-17、白介素-12/23 和白介素-23 抑制剂布罗达单抗、司库奇尤单抗、依奇珠单抗、乌司奴单抗、古塞库单抗、替西珠单抗和瑞莎珠单抗治疗中度至重度斑块状银屑病:随机对照试验的系统评价和网络荟萃分析。
J Immunol Res. 2019 Sep 10;2019:2546161. doi: 10.1155/2019/2546161. eCollection 2019.
2
Alopecia areata is characterized by dysregulation in systemic type 17 and type 2 cytokines, which may contribute to disease-associated psychological morbidity.斑秃的特征是全身17型和2型细胞因子失调,这可能导致与疾病相关的心理发病率。
Br J Dermatol. 2020 Jan;182(1):130-137. doi: 10.1111/bjd.18008. Epub 2019 Jul 17.
3
Interleukin-35 in immune-related diseases: protection or destruction.白细胞介素-35 在免疫相关疾病中的作用:保护还是破坏。
Immunology. 2019 May;157(1):13-20. doi: 10.1111/imm.13044. Epub 2019 Mar 7.
4
Clinical Significance of Decreased Interleukin-35 Expression in Patients with Psoriasis.银屑病患者白细胞介素-35表达降低的临床意义
Microbiol Immunol. 2018 May 26. doi: 10.1111/1348-0421.12605.
5
IL-17 inhibition: is it the long-awaited savior for alopecia areata?IL-17 抑制:它是斑秃患者期待已久的救星吗?
Arch Dermatol Res. 2018 Jul;310(5):383-390. doi: 10.1007/s00403-018-1823-y. Epub 2018 Mar 1.
6
Effective use of ustekinumab in a patient with concomitant psoriasis, vitiligo, and alopecia areata.优特克单抗在一名同时患有银屑病、白癜风和斑秃患者中的有效应用。
JAAD Case Rep. 2017 Sep 23;3(6):477-479. doi: 10.1016/j.jdcr.2017.07.009. eCollection 2017 Nov.
7
Interleukin-35 on B cell and T cell induction and regulation.白细胞介素-35对B细胞和T细胞的诱导与调节作用
J Inflamm (Lond). 2017 Aug 7;14:16. doi: 10.1186/s12950-017-0164-5. eCollection 2017.
8
The Immunobiology of Interleukin-35 and Its Regulation and Gene Expression.白细胞介素-35 的免疫生物学及其调控与基因表达。
Adv Exp Med Biol. 2016;941:213-225. doi: 10.1007/978-94-024-0921-5_10.
9
Interleukin-17 inhibitors. A new era in treatment of psoriasis and other skin diseases.白细胞介素-17抑制剂。银屑病及其他皮肤病治疗的新时代。
Postepy Dermatol Alergol. 2016 Aug;33(4):247-52. doi: 10.5114/ada.2016.61599. Epub 2016 Aug 16.
10
B cell activating factor and T-helper 17 cells: possible synergistic culprits in the pathogenesis of Alopecia Areata.B细胞活化因子与辅助性T细胞17:斑秃发病机制中可能的协同致病因素
Arch Dermatol Res. 2016 Mar;308(2):115-21. doi: 10.1007/s00403-016-1617-z. Epub 2016 Jan 21.